Researcher Live will be hosting a live panel discussion on academic entrepreneurship at 2pm GMT on the 8th December for our audience of researchers. The panel session will be discussing the steps and milestones needed to create a new, funded venture once a commercial opportunity has been identified within an academic environment.
The session will be chaired by Nick Gregg from Blenheim Chalcot, and joined by our Researcher CEO, Olly Cooper,.
Panellists:
- Isabel Fox, Partner at Syncona Investment Management Ltd
- Isabel Fox , General Partner at Outsized Ventures
- Matt White, Chief Commercialisation Officer of Frontier IP plc
- Nick Gregg, Managing Director at Blenheim Chalcot
Topics to be discussed will include:
- Initial structuring – what steps do you and your team need to take once you’ve identified a spin-out commercial opportunity?
- Preparation – how do you plan for raising funding for your new venture?
- Investor targeting – how do you identify and target the right investors for your business?
To ask questions or comment during the event, please click the 'raise hand' icon or submit a question/comment on slido.com using the #R0812.
Elisa Petris is a Partner at Syncona Investment Management Ltd. She is a Director on the Board of Quell Therapeutics, a biopharmaceutical company focusing on a range of autoimmune and inflammatory diseases, and the prevention of rejections in organ transplantation. Elisa was previously on the Board of Achilles Therapeutics, an oncology cell therapy company, and the former portfolio company Blue Earth Diagnostics. She was closely involved in the foundation of Quell, Blue Earth and Achilles Therapeutics, including their operational and strategic set-up.
Previously, she was a Senior Associate at Michel Dyens & Co. working on transactions covering the healthcare space, and a member of the Life Science team at L.E.K. Consulting based in London. While at L.E.K., she worked on projects for biotech, pharma and private equity clients. Elisa holds a PhD in Molecular Biology from Imperial College and an MBA from London Business School.
,Isabel FoxIsabel Fox is a General Partner at Outsized Ventures, an early stage venture capital fund based in London. Outsized Ventures partners with founders pushing the boundaries of science and technology to solve the world’s greatest challenges for the future of the planet, health and society.
Outsized ventures back transformational technology, including automation, artificial intelligence, quantum computing, virtual reality (VR) and augmented reality (AR). As part of a team of entrepreneurs and experienced investors, Isabel has invaluable experience enabling individuals and their companies to achieve maximum potential.
,Matt WhiteMatt White is Chief Commercialisation Officer of Frontier IP plc, a company whose focus is Intellectual Property (IP), specifically partnering with universities and research institutes to help commercialise technologies produced through academic research programmes. Matt works closely with portfolio companies to accelerate commercialisation. He has over 23 years’ experience in technology, product and service innovation, business development and marketing. In his previous role he was Head of Innovation, AB Sugar, part of FTSE 100 group AB Foods. He also has extensive experience working with university partners. He has an MA in Natural Sciences from Cambridge University.
,Nick GreggNick Gregg is an entrepreneur, investor and former equity analyst and strategy consultant. After leading the Blenheim Chalcot Investment Team for 4 years, Nick is now managing strategic projects for Blenheim Chalcot Founding Partners and exploring potential new venture opportunities.
DOI: nimLvz25cZUrK7xpOJZQ_prepost_1
Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.
Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.